Curaleaf Expands Retail Footprint with Dispensary Opening in Findlay, Ohio
MWN-AI** Summary
Curaleaf Holdings, Inc. has announced the opening of its latest dispensary in Findlay, Ohio, marking a significant expansion of its retail footprint in the state. This new location, at 2205 Tiffin Avenue, brings Curaleaf's total number of dispensaries in Ohio to five and its nationwide retail count to 162. The Findlay dispensary aims to enhance access to high-quality cannabis for both medical patients and adult-use consumers across Northwest Ohio.
Located in a bustling retail and dining area, the Findlay dispensary will offer a wide array of premium cannabis products from trusted brands, including Select BRIQ vape products, as well as Grassroots and Find high-quality flower options. Boris Jordan, Chairman and CEO of Curaleaf, emphasized that the opening is a crucial step in solidifying the company’s presence and commitment to Ohio's evolving cannabis market. The dispensary is designed to deliver an education-driven shopping experience, focusing on quality and community engagement.
Curaleaf Findlay will operate from 9:00 AM to 8:00 PM ET, Monday through Saturday, and 9:00 AM to 7:00 PM ET on Sundays. In addition to Findlay, Curaleaf also runs locations in Cuyahoga Falls, Girard, Lima, and Newark.
The company continues to position itself as a leading provider of consumer cannabis products, aiming to enhance lives through its diverse offerings and customer-centric approach. For more insights into their products and additional locations, customers can visit Curaleaf’s official website. With its expansion in Ohio, Curaleaf is well-poised to meet the growing demand within the state's cannabis market.
MWN-AI** Analysis
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) has recently opened its fifth dispensary in Ohio, located in Findlay. This expansion is part of Curaleaf's strategy to enhance its retail footprint across the United States, now boasting a total of 162 locations nationwide. This growth signifies Curaleaf's commitment to capturing market share in the burgeoning cannabis industry, particularly in key states where legalization is gaining momentum.
For investors, the opening of this dispensary presents an optimistic outlook for Curaleaf. By increasing accessibility to cannabis products for both medical and adult-use consumers in Northwest Ohio, Curaleaf situates itself to benefit from growing market demand. Given the location of the Findlay dispensary in a vibrant retail hub, the potential foot traffic could translate into robust sales growth, further solidifying Curaleaf's position as a leading provider in the cannabis sector.
Moreover, Curaleaf’s focus on offering a wide range of high-quality products from reputable brands demonstrates its commitment to excellence and customer satisfaction. This customer-first approach, coupled with an education-driven experience, could foster consumer loyalty and distinguish Curaleaf from its competitors, enhancing its brand value in the long term.
Despite the positive developments, potential investors should remain cautious. The cannabis industry is characterized by market volatility, regulatory uncertainties, and evolving public perceptions that may affect growth trajectories. It is advisable to monitor Curaleaf's operational performance closely, especially in terms of sales growth, profit margins, and customer engagement metrics.
In conclusion, Curaleaf's expansion in Findlay positions it favorably in a growing market, yet continued scrutiny of market conditions and company performance is essential for informed investment decision-making.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Fifth Ohio location brings national retail count to 162
STAMFORD, Conn., Feb. 25, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of its newest dispensary in Findlay, Ohio, located at 2205 Tiffin Avenue, Findlay, OH 45840. The store expands Curaleaf's footprint in the Buckeye State to five stores, bringing the Company's nationwide retail footprint to 162 locations. Curaleaf Findlay will increase access to high-quality cannabis for both medical patients and adult-use customers across Northwest Ohio.
Conveniently located in the heart of the area's vibrant retail and dining hub, Curaleaf Findlay is designed to serve both medical patients and adult-use customers with a broad selection of premium cannabis products. Customers can explore a wide variety of trusted, best-in-class brands and products including Select BRIQ all-in-one vape, as well as Find and Grassroots high-quality flower.
"Expanding into Findlay marks another important step in strengthening our footprint across Ohio and deepening our commitment to the state's evolving cannabis landscape," said Boris Jordan, Curaleaf Chairman and CEO. "This new dispensary reflects our focus on delivering a welcoming, education-driven experience rooted in quality, accessibility, and community engagement. We're proud to serve the people of Findlay and the surrounding Northwest Ohio region, and we look forward to providing both new and returning customers with best-in-class products, expert guidance, and a customer-first mindset."
Curaleaf Findlay is open 9:00 AM – 8:00 PM ET, Monday through Saturday and 9:00 AM – 7:00 PM ET on Sundays. Within the state of Ohio, Curaleaf currently operates retail locations in Cuyahoga Falls, Findlay, Girard, Lima, and Newark.
For more information on Curaleaf's dispensaries and products in Ohio and beyond, please visit: https://www.curaleaf.com/dispensary/ohio.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada, and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Findlay, Ohio. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com
Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com
SOURCE Curaleaf Holdings, Inc.
FAQ**
How does the opening of the Findlay, Ohio dispensary contribute to Curaleaf Holdings Inc CURLF's overall growth strategy in the cannabis market, particularly in terms of domestic expansion?
What specific products or brands will be emphasized at the new Curaleaf Holdings Inc CURLF dispensary in Findlay, and how does this selection cater to both medical patients and adult-use customers?
Can you elaborate on the community engagement initiatives that Curaleaf Holdings Inc CURLF plans to implement at the Findlay location, and how these align with the company's commitment to customer experience?
What are the anticipated challenges and opportunities that Curaleaf Holdings Inc CURLF expects to encounter in the Northwestern Ohio market following the opening of the Findlay dispensary?
**MWN-AI FAQ is based on asking OpenAI questions about Curaleaf Holdings Inc (OTC: CURLF).
NASDAQ: CURLF
CURLF Trading
-1.7% G/L:
$2.251 Last:
41,543 Volume:
$2.21 Open:
